{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:37:53Z","timestamp":1789627073914,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000948","name":"Pfizer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000948","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gilead Sciences Inc."},{"name":"MSD Australia"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijantimicag.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:38:57Z","timestamp":1471048737000},"page":"453-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations"],"prefix":"10.1016","volume":"48","author":[{"given":"Catriona L.","family":"Halliday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon C.-A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"van Hal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina J.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Daveson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania C.","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Orla","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0010","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10096-015-2374-1","article-title":"Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification","volume":"34","author":"Araujo","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cmi.2014.12.021","article-title":"Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality","volume":"21","author":"Slavin","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2016.07.005_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2016.07.005_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2016.07.005_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/1469-0691.12515","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi","volume":"20","author":"Chowdhary","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0035","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0040","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2008.02086.x","article-title":"EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0045","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/JCM.01187-06","article-title":"Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B","volume":"44","author":"Espinel-Ingroff","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0050","first-page":"280","article-title":"In vitro susceptibility testing of Aspergillus and non-Aspergillus filamentous moulds to antifungal agents: evaluation of three different methods","volume":"5","author":"Mirchevska","year":"2012","journal-title":"Maced J Med Sci"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0055","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/JCM.00287-07","article-title":"Clinical evaluation of the Sensititre YeastOne plate for testing susceptibility of filamentous fungi to posaconazole","volume":"45","author":"Patel","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0060","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/imj.12598","article-title":"Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014","volume":"44","author":"Blyth","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/AAC.45.1.327-330.2001","article-title":"In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates","volume":"45","author":"Arikan","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0070","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.05910-11","article-title":"Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species","volume":"56","author":"Lackner","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0075","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1128\/JCM.02415-10","article-title":"Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study","volume":"49","author":"Wang","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AAC.46.1.62-68.2002","article-title":"In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates","volume":"46","author":"Meletiadis","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0085","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/13693780802510224","article-title":"Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi","volume":"47","author":"Wiederhold","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0090","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.01539-06","article-title":"In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest","volume":"51","author":"Torres-Narbona","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0095","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.01618-06","article-title":"Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex","volume":"51","author":"Azor","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0100","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/AAC.01467-08","article-title":"Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers","volume":"53","author":"Alastruey-Izquierdo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.07.005_bib0105","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.04435-14","article-title":"Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales","volume":"59","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916301996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916301996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T07:20:16Z","timestamp":1536477616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857916301996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0924857916301996"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.07.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}